"Fatebenefratelli Isola Tiberina - Gemelli Isola" Trials

"Fatebenefratelli Isola Tiberina - Gemelli Isola"	Welcome, Profile Billing Logout

"Fatebenefratelli Isola Tiberina - Gemelli Isola"

Welcome, Profile Billing Logout

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Frontoni, Simona

QWINT-4, NCT05462756 / 2021-005878-25: A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections

Completed

730

Europe, US, RoW

Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Lispro (U100), Humalog, Insulin Glargine (U100), Basaglar

Eli Lilly and Company, Eli Lilly and Company

Type 2 Diabetes, Type 2 Diabetes Treated With Insulin

02/24

cassetta, emanuele

TRAILBLAZER-ALZ 6, NCT05738486: A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease

Active, not recruiting

800

Europe, US

Donanemab, LY3002813, Placebo

Eli Lilly and Company

Alzheimer's Disease, Dementia, Brain Diseases, Central Nervous System Diseases, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Mental Disorders

05/24

05/25